Gonorrhea and chlamydia in emergency departments: Screening, diagnosis and treatment

被引:40
作者
Mehta S.D. [1 ]
机构
[1] Department of Epidemiology and Biostatistics, School of Public Health, University of Illinois Chicago, Chicago, IL 60612
关键词
Emergency Department; Sexually Transmitted Infection; Chlamydia Trachomatis; Gonorrhea; Chlamydia Screening;
D O I
10.1007/s11908-007-0009-0
中图分类号
学科分类号
摘要
Failure to screen sexually active adolescents and adults for gonorrhea and chlamydia at the time of acute care visits to urban emergency departments (ED) results in missed treatment opportunities for 38% to 82% of infected persons. The prevalence of gonorrhea and chlamydia infections among ED patients presenting with genitourinary or pregnancy-related complaints or providing urine specimens as part of routine medical care ranges from 4.3% ot 16.4%. Notably, prevalence among general ED patients is similar (9.7%-14.3%). Due to the asymptomatic or nonspecific presentation of these infections, expanded screening is recommended to increase detection, treatment, and partner notification. A lower threshold of empiric treatment in the ED setting is recommended due to the difficulty and incompleteness of follow-up subsequent to ED discharge. Specific recommendations to improve the quality of ED care for sexually transmitted infections and to expand detection are provided. Copyright © 2007 by Current Medicine Group LLC.
引用
收藏
页码:134 / 142
页数:8
相关论文
共 42 条
[1]  
Sexually Transmitted Disease Surveillance, 2004, (2005)
[2]  
Weinstock H., Berman S., Cates Jr. W., Sexually transmitted diseases among American youth: Incidence and prevalence estimates, 2000, Perspect Sex Reprod Health, 36, pp. 6-10, (2004)
[3]  
The Hidden Epidemic: Confronting Sexually Transmitted Diseases, (1997)
[4]  
Westrom L., Riduan J., Reynolds G., Et al., Pelvic inflammatory disease and fertility, Sex Transm Dis, 19, pp. 185-192, (1992)
[5]  
Quinn T.C., Gaydos C., Shepherd M., Et al., Epidemiologic and microbiologic correlates of Chlamydia trachomatis infection in sexual partnerships, JAMA, 276, pp. 1737-1742, (1996)
[6]  
Hook III E.W., Richey C.M., Leone P., Et al., Delayed presentations to clinics for sexualiy transmitted diseases by symptomatic patients. A potential contributor to continuing STD morbidity, Sex Transm Dis, 24, pp. 443-448, (1997)
[7]  
Hook III E.W., Spitters C., Reichart C.A., Et al., Use of cell culture and a rapid diagnostic assay for Chlamydia trachomatis screening, JAMA, 272, pp. 867-870, (1994)
[8]  
Scholes D., Stergachis A., Heidrich F.E., Et al., Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection, N Engl J Med, 334, pp. 1362-1366, (1996)
[9]  
Hu D., Hook III E.W., Goldie S.J., Screening for Chlamydia trachomatis in women 15 to 29 years of age: A cost-effectiveness analysis, Ann Intern Med, 141, pp. 501-513, (2004)
[10]  
Honey E., Augood C., Templeton A., Et al., Cost effectiveness of screening for Chlamydia trachomatis: A review of published studies, Sex Transm Infect, 78, pp. 406-412, (2002)